|4Oct 26, 5:54 PM ET

Hannah Brendan 4

4 · Quince Therapeutics, Inc. · Filed Oct 26, 2023

Insider Transaction Report

Form 4
Period: 2023-10-24
Hannah Brendan
CBO, COO & CCO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-10-24+75,00075,000 total
    Exercise: $0.99Exp: 2033-10-23Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]1/48th of the total number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the vesting commencement date of October 23, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION